Editor-in-Chief, Bio-IT World
Editor-in-Chief of Bio-IT World, a trade magazine covering the role of technology in the life sciences, and author of The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine
PROFILE
Kevin Davies
Guest
FROM Kevin Davies
Which Way, L.A.?
Genome Companies Dominate the Southland Last week, we talked about the development of genome sequencing , which took 10 years and $2 billion twenty years ago. Since then, it’s developed at an astonishing pace, centered in Southern California. Kevin Davies is editor-in-chief of Bio-IT World and author of The $1000 Genome : The Revolution in DNA Sequencing and the New Era of Personalized Medicine.
To the Point
The $1,000 Genome and 'Personalized Medicine' It took $2 billion and ten years to complete the Human Genome Project . Now, just ten years later, many individuals have had their genomes sequenced, and the cost keeps dropping. Kevin Davies is editor of Bio-IT World , which covers the role of technology in the life sciences. He's also the author of The $1000 Genome : The Revolution in DNA Sequencing and the New Era of Personalized Medicine.
Recommended
To the Point
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.
To the Point
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.